The Numbers Game

Discussion in 'Salix' started by anonymous, May 6, 2021 at 9:16 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Funny how only TX is getting credit for a nationally promoted specialty pharmacy...... located in Florida?

    Kudos to whoever pulled that one off!

    opening weekly reports is a joke at this point
     

  2. anonymous

    anonymous Guest

    Don’t blame Texas, it’s only two territories taking all the scripts.

    Other Texas reps are getting screwed as well while Austin and SA get max bonuses every quarter.
     
  3. anonymous

    anonymous Guest

    Why won’t management push back on this? It impacts their bonus and ranking too
     
  4. anonymous

    anonymous Guest

    Because the scripts all roll up to the top regardless. Reps and managers get screwed. RDs not quite as much and Josh feels zero impact. This has been going on for five fucking years. The best is when fat boy tells the RD to tell the manager that rep X needs to be on a plan and moved out even when he knows the scripts are being bled out of their territory by a national GI group based in Texas with their own specialty pharmacy. It's been communicated in great detail. Texas Digestive Disease Consultants (TDDC) is a nationally integrated group managed by a Chicago based multi billion dollar hedge and venture capital group called Waud Capital. They control the largest GI team in the nation through their group GI Alliance. GI Alliance now has more than 150 centers in 8 states including: Illinois, Indiana, Arkansas, Oklahoma, Mississippi, Louisiana, Arizona AND Texas. All prescriptions for practitioners in these groups are credited back to TDDC and they don't report physician level data. They run 31 clinics and GI centers alone in Illinois and Arizona which is just slightly less than they have in Texas. But San Antonio gets all the credit. HR was dragged into the discussion a few years ago by DC because his reps were losing bonus money they rightfully earned. It's an easy fix through IMS but Labat is too lazy and stupid to normalize the reporting and push credit to the right territories. RDs are COWARDS too scared challenge the data to support the managers. And JC just doesn't care.

    San Antonio is like the guy in the movie "There Will Be Blood." "I drink your milkshake....."
     
  5. anonymous

    anonymous Guest

    Shady shady shady shut going down all over
     
  6. anonymous

    anonymous Guest

    I am a manager. This is true and we all want to puke every time we hear Coyle cheering on the San Antonio team. He knows the negative impact this has on multiple teams and refuses to fix it. If you bring it up, you are labeled a troublemaker and told to keep your thoughts to yourself.
     
  7. anonymous

    anonymous Guest

    thats fuck!!ng criminal
     
  8. anonymous

    anonymous Guest

    Agreed and there are many other scenarios similar to this happening around the Nation.
    Jabba doesnt care because it doesnt impact him and the directors only get hit a little so they arent willing to go to bat for their DM’s and Reps. Its really pretty sad!!!
     
  9. anonymous

    anonymous Guest

    As long as the same territories are sent to PC year after year regardless of their efforts to impact sales, you will continue to see a mass exodus to other GI companies who are willing to at least “make”the bonus structure and PC win look fair. Salix used to respect its employees and reward effort, now the goal is to put you on a plan based on unfair data collection that favors the same territories year after year. The contests are unfortunately all set up to reward these same territories as well. I am hoping these inequity will be addressed once the company completes the restructuring but am not going to hold my breath.
     
  10. anonymous

    anonymous Guest

    None of it will be addressed. JC will just call any shortcomings up to “They’ve been here too long. No fire in the belly. Move em out.” You think I’m kidding? I’ve heard him say those exact words when talking about some of our best and most consistent performers.
     
  11. anonymous

    anonymous Guest


    So JC believes “top performers” only live in the same five cities??? Some of these clowns haven’t been to work in over a year. Everything is “closed” in their territory due to the pandemic but somehow they stay 130% to goal regardless. I know one rep who always floats around at the top, and they’ve never really worked. They’re a personal trainer! Can’t blame them for working a sweet deal, but management knows about it and does nothing. Meanwhile the rest of us are being chastised for not having enough weekly in-services, and hoping to be lucky enough to get to a 10k bonus for once.
    I understand some grass is just greener— that’s life. But the disparity in data tracking/reporting by territory is incredible. It wasn’t this bad even during the Valeant days here....
     
  12. anonymous

    anonymous Guest

    You need to know that JC has never been a rep, DM or RD. He went straight from Valeant marketing to VP of sales at Orapharma. For some reason McKenna loved him and thought it would be a great idea to put him in charge of the single biggest revenue brand at BHC. His lack of experience in the field makes it impossible for him to understand how reporting and analytics predict outcomes. JC won’t admit that he has no perspective or experience to guide his decisions. As long as the National number rolls up, he doesn’t care if the same handful of people win every year. And he is not interested in morale or turnover. He has said publicly that we are all replaceable at a lower price. You don’t like it here? Leave. JC will find someone younger and cheaper to replace you. Think about the last couple of live meetings we had. How many “new” team members did you meet for the first time? Do they still have people stand up based on 15,10 or 5 year service anniversaries? We are not valued.
     
  13. anonymous

    anonymous Guest

    There is no long term plan here so why invest time and money to make the sales reporting work? Xifaxan patent challenges are already mounted by Teva, Watson and Novartis. Papa just announced a plan to swing B&L into a stand alone company with him as the CEO. The RemainCo. (That's what they refer to assets remaining after a spin off) will be everything outside eye care. We are part of RemainCo. BHC debt is being pushed to the remaining assets to the tune of nearly 7 times leverage freeing up B&L to continue along making roughly $5BB per year out from under the back breaking debt that BHC still carries. RemainCo assets like Salix can be broken up too service the remaining debt. If you listened to the earnings call, this was all spelled out. We may be for sale or maybe not. But one thing is certain; there is no long term plan for Salix. Squeeze as much out of X550 as possible and sell it off.
     
  14. anonymous

    anonymous Guest

    That is JC’s mentality . Its sad but very true.
    I have heard him say the exact thing. FK is not much better , you can be coming off of a P Club year and if the #’s turn then suddenly you are worthless and he forces your DM to put you on a PIP- unreal...
     
  15. anonymous

    anonymous Guest

    Josh is just another desperate, grasping, scraping loser and the RDs all bow to him. Another moron who bought more house than he can afford and then VRX crashed. They NEED the sales force to do better. Otherwise they can’t cover that jumbo mortgage payment. Loser.
     
  16. anonymous

    anonymous Guest

    this entire company is riddled with cancerous tumors where leaders should be
     
  17. anonymous

    anonymous Guest

    Vultures feeding off the same rotting carcass.
     
  18. anonymous

    anonymous Guest

    You are partially wrong my friend.
    You dont “lose” when stock is given to you (unlike options) Sure, its not worth as much as it could, but over the last 6-7 years the stock is still up over 25% on a cost basis. So I think that they are still doing pretty damn well with their “free” money...
     
  19. anonymous

    anonymous Guest

    There for sure needs to be an investigation whether by Medical Board or DOJ into this HOC (aka “study”) that is paying for patient information and re-routing commercially insured pts to a FL pharmacy to fill only Xifaxan (not even lactulose which would be standard of care). I wonder who benefits from those Xifaxan scripts being filled at this specific pharmacy that obviously orders in bulk. Who is getting a kickback here? Could it be the author of this “study” , coming out of San Antonio? Last I checked studies provided free medication to patients at no cost (not billing their insurance), and they treated the disease state according to standard of care.
     
  20. anonymous

    anonymous Guest

    FYI - the San Antonio HOC does not help patients without insurance or who are part of a federally funded program. Why?